 Influenza Vaccines
"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.
| Descriptor ID |
D007252
|
| MeSH Number(s) |
D20.215.894.899.302
|
| Concept/Terms |
Influenza Vaccines- Influenza Vaccines
- Vaccines, Influenza
- Influenzavirus Vaccines
- Vaccines, Influenzavirus
- Influenza Virus Vaccines
- Vaccines, Influenza Virus
- Virus Vaccines, Influenza
- Flu Vaccines
- Vaccines, Flu
- Influenza Vaccine
- Vaccine, Influenza
FluMist- FluMist
- MedImmune Vaccines Brand of Trivalent Live Attenuated Influenza Vaccine
- CAIV-T vaccine
|
Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".
This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 0 | 2 | | 1999 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2003 | 2 | 1 | 3 | | 2004 | 2 | 0 | 2 | | 2006 | 1 | 1 | 2 | | 2007 | 3 | 0 | 3 | | 2008 | 6 | 0 | 6 | | 2009 | 1 | 0 | 1 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 1 | 3 | | 2012 | 1 | 0 | 1 | | 2013 | 2 | 0 | 2 | | 2014 | 1 | 0 | 1 | | 2016 | 1 | 1 | 2 | | 2017 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.
-
Moulia DL, Dopson SA, Vagi SJ, Fitzgerald TJ, Fiebelkorn AP, Graitcer SB. Readiness to Vaccinate Critical Personnel During an Influenza Pandemic, United States, 2015. Am J Public Health. 2017 10; 107(10):1643-1645.
-
Giarola-Silva S, Coelho-Dos-Reis JGA, Mourão MM, Campi-Azevedo AC, Nakagaki Silva EE, Luiza-Silva M, Martins MA, Silveira-Cassette ACO, Batista MA, Peruhype-Magalhães V, Antonelli LRDV, Leite Ribeiro JG, Elói-Santos SM, Machado AV, Teixeira-Carvalho A, Martins-Filho OA, Araújo MSS. Distinct patterns of cellular immune response elicited by influenza non-adjuvanted and AS03-adjuvanted monovalent H1N1(pdm09) vaccine. Antiviral Res. 2017 08; 144:70-82.
-
Bolduc P, Roder N, Colgate E, Cheeseman SH. Care of Patients With HIV Infection: Primary Care. FP Essent. 2016 Apr; 443:31-42.
-
Ramirez A, Co M, Mathew A. CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice. PLoS One. 2016; 11(3):e0150425.
-
Wu WC, Jiang L, Friedmann PD, Trivedi A. Association between process quality measures for heart failure and mortality among US veterans. Am Heart J. 2014 Nov; 168(5):713-20.
-
Tan YC, Blum LK, Kongpachith S, Ju CH, Cai X, Lindstrom TM, Sokolove J, Robinson WH. High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin Immunol. 2014 Mar; 151(1):55-65.
-
Moise L, Tassone R, Latimer H, Terry F, Levitz L, Haran JP, Ross TM, Boyle CM, Martin WD, De Groot AS. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice. Hum Vaccin Immunother. 2013 Oct; 9(10):2060-8.
-
Almansour I, Chen H, Wang S, Lu S. Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years. Hum Vaccin Immunother. 2013 Oct; 9(10):2049-59.
-
Golekoh MC, Hu S, Norman AM, Horn PS, Brady RC, Wong BL. Comparison of the immunogenicity of intramuscular versus subcutaneous administration of trivalent inactivated influenza vaccine in individuals with neuromuscular diseases. J Child Neurol. 2013 May; 28(5):596-601.
-
Co MD, Cruz J, Takeda A, Ennis FA, Terajima M. Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals. Hum Vaccin Immunother. 2012 Sep; 8(9):1218-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|